|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/496 | (2006.01) |
| (11) | Number of the document | 3185867 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15836431.5 |
| Date of filing the European patent application | 2015-08-24 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation | 2021-06-10 |
| (86) | Number | PCT/US2015/046525 |
| Date | 2015-08-24 |
| (87) | Number | WO 2016/032950 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462041341 P | 2014-08-25 | US |
| (72) |
MORALES, Wilfredo Jr., US
ZEIDAN, Tarek A., US
CHIARELLA, Renato A., US
WRIGHT, Steven G., US
PERRY, Jason M., US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Apiprazolo darinių kristalizavimo procesas prailginto atpalaidavimo vaisto formose, skirtose šizofrenijos gydymui |
| CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA |
| Payment date | Validity (years) | Amount | |
| 2025-07-31 | 11 | 289.00 EUR |
| 2026-08-24 |